Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
T-Mobile US | TMUS | 4. oct 2024 | 208.28 | +0.12 |
T. Rowe Price Blue Chip Growth ETF | TCHP | 4. oct 2024 | 39.64 | +0.79 |
T. Rowe Price Dividend Growth ETF | TDVG | 4. oct 2024 | 40.69 | +0.49 |
T. Rowe Price Equity Income ETF | TEQI | 4. oct 2024 | 41.83 | +1.03 |
T. Rowe Price Group | TROW | 4. oct 2024 | 108.47 | +1.87 |
T. Rowe Price Growth Stock ETF | TGRW | 4. oct 2024 | 37.54 | +1.11 |
T2 Biosystems | TTOO | 4. oct 2024 | 1.82 | 0.00 |
Taboola.com | TBLA | 4. oct 2024 | 3.28 | +4.46 |
Tactile Systems Technology | TCMD | 4. oct 2024 | 14.45 | -0.14 |
Taitron Components A | TAIT | 4. oct 2024 | 2.91 | -1.52 |
Taiwan Fund | TWN | 4. oct 2024 | 43.53 | -0.50 |
Taiwan Index MSCI Ishares | EWT | 4. oct 2024 | 53.78 | +0.24 |
Taiwan Semiconductor Manufacturing ADR | TSM | 4. oct 2024 | 181.16 | +0.94 |
Take-Two Interactive Software | TTWO | 4. oct 2024 | 151.69 | +2.73 |
Takeda Pharmaceutical ADR | TAK | 4. oct 2024 | 14.43 | +1.33 |
TAL Education Group ADR | TAL | 4. oct 2024 | 11.50 | +0.97 |
Talen Energy | TLN | 4. oct 2024 | 190.35 | 0.00 |
Talis Biomedical | TLIS | 4. oct 2024 | 4.38 | 0.00 |
Talkspace | TALK | 4. oct 2024 | 2.47 | +3.78 |
Talos Energy | TALO | 4. oct 2024 | 11.29 | +1.26 |
Talphera | TLPH | 4. oct 2024 | 0.78 | -1.27 |
Tamboran Resources | TBN | 4. oct 2024 | 20.00 | +1.52 |
Tandem Diabetes Care | TNDM | 4. oct 2024 | 41.78 | +3.26 |
Tanger | SKT | 4. oct 2024 | 33.42 | +2.42 |
Tango Therapeutics | TNGX | 4. oct 2024 | 6.98 | +1.16 |
Tantech | TANH | 4. oct 2024 | 0.19 | -10.75 |
Taoping | TAOP | 4. oct 2024 | 0.84 | +28.68 |
Tapestry | TPR | 4. oct 2024 | 46.50 | +1.64 |
Targa Resources | TRGP | 4. oct 2024 | 158.02 | +1.62 |
Target | TGT | 4. oct 2024 | 152.88 | +2.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.